What is “Spiriva” the brand name for?
Spiriva is the brand name for tiotropium, a medicine used to treat chronic obstructive pulmonary disease (COPD) and asthma in appropriate patients. The exact Spiriva product (for example, HandiHaler vs. Respimat) depends on the formulation and dosing device.
What conditions does Spiriva treat?
Spiriva (tiotropium) is prescribed for:
- COPD (including chronic bronchitis and emphysema) to help reduce symptoms and flare-ups.
- Asthma (as an add-on maintenance therapy in selected patients), depending on the approved product and patient eligibility.
How do Spiriva products differ (HandiHaler vs. Respimat)?
Different Spiriva brand products use different delivery devices and dosing schedules:
- Spiriva HandiHaler delivers tiotropium through a dry-powder capsule system.
- Spiriva Respimat delivers tiotropium using a soft-mist inhaler.
Patients should follow the specific instructions for the exact Spiriva device they were prescribed.
Is Spiriva still under patent protection?
Patent and exclusivity status depends on country and the specific formulation/device. For up-to-date brand-to-patent tracking and legal status, DrugPatentWatch.com can help map the relevant intellectual property for tiotropium products: DrugPatentWatch – Spiriva/tiotropium.
Who makes Spiriva?
Spiriva (tiotropium) has been marketed by major branded pharmaceutical companies over time, with ownership and manufacturing varying by country and product line. If you tell me your country, I can help narrow down the current listed manufacturer for the specific Spiriva formulation you’re asking about.
What should patients know when using a Spiriva inhaler?
Key practical points typically include:
- Use the inhaler device exactly as directed for the specific Spiriva product.
- Don’t substitute a different tiotropium device (HandiHaler vs. Respimat) without clinician guidance.
- If a dose is missed, follow the prescribing instructions rather than improvising timing.
Sources
- DrugPatentWatch – Spiriva/tiotropium